[
  {
    "ts": "2025-09-12T17:48:15+00:00",
    "headline": "AbbVie Shares Hit Record High on Rinvoq Exclusivity Extension to 2037",
    "summary": "Extra four years of exclusivity boosts long-term growth outlook",
    "url": "https://finance.yahoo.com/news/abbvie-shares-hit-record-high-174815473.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "d93e3353-d044-343d-87ed-aa946a345ec1",
      "content": {
        "id": "d93e3353-d044-343d-87ed-aa946a345ec1",
        "contentType": "STORY",
        "title": "AbbVie Shares Hit Record High on Rinvoq Exclusivity Extension to 2037",
        "description": "",
        "summary": "Extra four years of exclusivity boosts long-term growth outlook",
        "pubDate": "2025-09-12T17:48:15Z",
        "displayTime": "2025-09-12T17:48:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/176ff17575abbf2ce6fe794c8d300f90",
          "originalWidth": 550,
          "originalHeight": 367,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8Z3Bg4gpFU6I2uqsRy6Ujw--~B/aD0zNjc7dz01NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/176ff17575abbf2ce6fe794c8d300f90.cf.webp",
              "width": 550,
              "height": 367,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8U1nxEHnFV9tpPMDmJ0psQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/176ff17575abbf2ce6fe794c8d300f90.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-shares-hit-record-high-174815473.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-shares-hit-record-high-174815473.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-12T16:11:00+00:00",
    "headline": "Prescription Drug Ads Face Big Changes. These Stocks Could Get Hurt the Most.",
    "summary": "Big changes could be coming to pharmaceutical advertising on TV, potentially causing problems for the broadcasters and networks that get paid to host those commercials.  TV watchers have become all too familiar with seeing prescription drug ads while watching their favorite programs.  Hearing personal stories about how  Novo Nordisk’s  Wegovy led to weight loss or that “healing is possible” with  Johnson & Johnson’s  Tremfya has become routine for viewers.",
    "url": "https://www.barrons.com/articles/disney-comcast-nexstar-stock-drug-ad-reforms-b6cf01cc?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "58217ebd-d4b9-3fe5-8cfc-9309aa8f127e",
      "content": {
        "id": "58217ebd-d4b9-3fe5-8cfc-9309aa8f127e",
        "contentType": "STORY",
        "title": "Prescription Drug Ads Face Big Changes. These Stocks Could Get Hurt the Most.",
        "description": "",
        "summary": "Big changes could be coming to pharmaceutical advertising on TV, potentially causing problems for the broadcasters and networks that get paid to host those commercials.  TV watchers have become all too familiar with seeing prescription drug ads while watching their favorite programs.  Hearing personal stories about how  Novo Nordisk’s  Wegovy led to weight loss or that “healing is possible” with  Johnson & Johnson’s  Tremfya has become routine for viewers.",
        "pubDate": "2025-09-12T16:11:00Z",
        "displayTime": "2025-09-12T16:11:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/58217ebd-d4b9-3fe5-8cfc-9309aa8f127e/prescription-drug-ads-face.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/a9c329568e1b5a74039fb43af17343fe",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uzInzhhAJXxm_MjyOievvA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/a9c329568e1b5a74039fb43af17343fe.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ICWIgitC3pDpeJnvQt8RWw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/a9c329568e1b5a74039fb43af17343fe.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/disney-comcast-nexstar-stock-drug-ad-reforms-b6cf01cc?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "NXST"
            },
            {
              "symbol": "DIS"
            },
            {
              "symbol": "CMCSA"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-12T13:57:00+00:00",
    "headline": "AbbVie Stock Hit a Record on ‘Big Win’ for Blockbuster Drug. The Case for Buying In.",
    "summary": "Shares of  AbbVie  closed at a record after it struck a deal that will extend patent exclusivity for its blockbuster autoimmune medicine Rinvoq until 2037.  The patent extension is a positive for AbbVie as it continues to deal with declining sales of its former cash cow Humira, which lost patent protection in 2023.  It’s a “big win for Rinvoq,” said William Blair analysts led by Matt Phipps.",
    "url": "https://www.barrons.com/articles/abbvie-stock-rinvoq-7b5684a3?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "0e833978-06c4-338a-b6d0-723d3bad751a",
      "content": {
        "id": "0e833978-06c4-338a-b6d0-723d3bad751a",
        "contentType": "STORY",
        "title": "AbbVie Stock Hit a Record on ‘Big Win’ for Blockbuster Drug. The Case for Buying In.",
        "description": "",
        "summary": "Shares of  AbbVie  closed at a record after it struck a deal that will extend patent exclusivity for its blockbuster autoimmune medicine Rinvoq until 2037.  The patent extension is a positive for AbbVie as it continues to deal with declining sales of its former cash cow Humira, which lost patent protection in 2023.  It’s a “big win for Rinvoq,” said William Blair analysts led by Matt Phipps.",
        "pubDate": "2025-09-12T13:57:00Z",
        "displayTime": "2025-09-12T13:57:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/0e833978-06c4-338a-b6d0-723d3bad751a/abbvie-stock-hit-a-record-on.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/e0e73cec6711c9af8fc0c919cc1ffadd",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AUMQE6rlIPt4dCGUiOs_Xw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/e0e73cec6711c9af8fc0c919cc1ffadd.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Sc5SyCgfIAZl0d2DyWRqwQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/e0e73cec6711c9af8fc0c919cc1ffadd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/abbvie-stock-rinvoq-7b5684a3?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-12T13:21:00+00:00",
    "headline": "AbbVie Settles Rinvoq Patent Dispute: What It Means for the Stock",
    "summary": "ABBV secures Rinvoq's market lead until 2037, boosting shares as strong sales and new indications fuel long-term growth prospects.",
    "url": "https://finance.yahoo.com/news/abbvie-settles-rinvoq-patent-dispute-132100517.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "b5ee49f3-06a7-3e2a-be14-97a573fd0148",
      "content": {
        "id": "b5ee49f3-06a7-3e2a-be14-97a573fd0148",
        "contentType": "STORY",
        "title": "AbbVie Settles Rinvoq Patent Dispute: What It Means for the Stock",
        "description": "",
        "summary": "ABBV secures Rinvoq's market lead until 2037, boosting shares as strong sales and new indications fuel long-term growth prospects.",
        "pubDate": "2025-09-12T13:21:00Z",
        "displayTime": "2025-09-12T13:21:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OQG3.5Wd9P9R69q2rhm9rA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pBlncPVBhEXpjxtBDlEOsg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-settles-rinvoq-patent-dispute-132100517.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-12T13:18:00+00:00",
    "headline": "Company News for Sep 12, 2025",
    "summary": "Companies in The News Are: TSLA, WBD, DOW, ABBV",
    "url": "https://finance.yahoo.com/news/company-news-sep-12-2025-131800888.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "26346818-612c-3a50-bf87-e552ccf8783b",
      "content": {
        "id": "26346818-612c-3a50-bf87-e552ccf8783b",
        "contentType": "STORY",
        "title": "Company News for Sep 12, 2025",
        "description": "",
        "summary": "Companies in The News Are: TSLA, WBD, DOW, ABBV",
        "pubDate": "2025-09-12T13:18:00Z",
        "displayTime": "2025-09-12T13:18:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/affdd39d2cfb5dfef2e1f5541ff50f90",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fwwhaKspVAOO43l.1gnL6A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/affdd39d2cfb5dfef2e1f5541ff50f90.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uhgu4jglOv5eUmK2o5oK0w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/affdd39d2cfb5dfef2e1f5541ff50f90.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/company-news-sep-12-2025-131800888.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/company-news-sep-12-2025-131800888.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DOW"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "WBD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-12T12:55:38+00:00",
    "headline": "AbbVie settles litigation with all generic manufacturers of Rinvoq",
    "summary": "AbbVie (ABBV) announced that it has settled litigation with all generic manufacturers that filed abbreviated new drug applications with the Food and Drug Administration for generic versions of upadacitinib tablets, which AbbVie markets as Rinvoq. “Given the settlement and license agreements, which are subject to standard acceleration provisions, assuming pediatric exclusivity is granted, no generic entry for any upadacitinib tablets is expected prior to April 2037 in the United States,” the comp",
    "url": "https://finance.yahoo.com/news/abbvie-settles-litigation-generic-manufacturers-125538683.html",
    "source": "TipRanks",
    "provider": "yfinance",
    "raw": {
      "id": "52d0fa60-a2fc-3a61-b8ad-f2318b7c24a0",
      "content": {
        "id": "52d0fa60-a2fc-3a61-b8ad-f2318b7c24a0",
        "contentType": "STORY",
        "title": "AbbVie settles litigation with all generic manufacturers of Rinvoq",
        "description": "",
        "summary": "AbbVie (ABBV) announced that it has settled litigation with all generic manufacturers that filed abbreviated new drug applications with the Food and Drug Administration for generic versions of upadacitinib tablets, which AbbVie markets as Rinvoq. “Given the settlement and license agreements, which are subject to standard acceleration provisions, assuming pediatric exclusivity is granted, no generic entry for any upadacitinib tablets is expected prior to April 2037 in the United States,” the comp",
        "pubDate": "2025-09-12T12:55:38Z",
        "displayTime": "2025-09-12T12:55:38Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/tipranks_452/3c4cd7a27c93504ea012b7142e0075b5",
          "originalWidth": 192,
          "originalHeight": 192,
          "caption": "https://www.tipranks.com/news/the-fly/abbvie-settles-litigation-with-all-generic-manufacturers-of-rinvoq-thefly",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w8eeHWtv.w9lRpzA.15U0g--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/3c4cd7a27c93504ea012b7142e0075b5.cf.webp",
              "width": 192,
              "height": 192,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gbABLmEUFTq18nWkvQucyQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/3c4cd7a27c93504ea012b7142e0075b5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "TipRanks",
          "url": "https://www.tipranks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-settles-litigation-generic-manufacturers-125538683.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-settles-litigation-generic-manufacturers-125538683.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-12T11:25:56+00:00",
    "headline": "AbbVie extends Rinvoq exclusivity by four years after generics settlements",
    "summary": "AbbVie has signed deals with Rinvoq generic hopefuls as it extends protection for one of its prized assets until 2037.",
    "url": "https://www.pharmaceutical-technology.com/news/abbvie-extends-rinvoq-exclusivity-by-four-years-after-generics-settlements/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "c8ae343e-a14f-3880-8b46-3aa872316fde",
      "content": {
        "id": "c8ae343e-a14f-3880-8b46-3aa872316fde",
        "contentType": "STORY",
        "title": "AbbVie extends Rinvoq exclusivity by four years after generics settlements",
        "description": "",
        "summary": "AbbVie has signed deals with Rinvoq generic hopefuls as it extends protection for one of its prized assets until 2037.",
        "pubDate": "2025-09-12T11:25:56Z",
        "displayTime": "2025-09-12T11:25:56Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/6435526ebddd6269916953ac718f7456",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wpZvSpCR5Wjr2ukvpa.5bw--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/6435526ebddd6269916953ac718f7456.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yspUmDfjI4exj4twMLQlDA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/6435526ebddd6269916953ac718f7456.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/abbvie-extends-rinvoq-exclusivity-by-four-years-after-generics-settlements/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-extends-rinvoq-exclusivity-four-112556351.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-12T08:46:00+00:00",
    "headline": "The Best Stocks to Invest $50,000 In Right Now",
    "summary": "These stocks have what it takes to succeed over the long run.",
    "url": "https://www.fool.com/investing/2025/09/12/the-best-stocks-to-invest-50000-in-right-now/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "a8496919-65fd-34a0-b016-3ec723f06020",
      "content": {
        "id": "a8496919-65fd-34a0-b016-3ec723f06020",
        "contentType": "STORY",
        "title": "The Best Stocks to Invest $50,000 In Right Now",
        "description": "",
        "summary": "These stocks have what it takes to succeed over the long run.",
        "pubDate": "2025-09-12T08:46:00Z",
        "displayTime": "2025-09-12T08:46:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/bebbbbea7a8dc1ba783fb2a1b226b165",
          "originalWidth": 1400,
          "originalHeight": 934,
          "caption": "A smiling person with hands behind head.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Cnb8S07N5NRUtswBRh26cQ--~B/aD05MzQ7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/bebbbbea7a8dc1ba783fb2a1b226b165.cf.webp",
              "width": 1400,
              "height": 934,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yqnynCedrRL4KP.q03WFyw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/bebbbbea7a8dc1ba783fb2a1b226b165.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/09/12/the-best-stocks-to-invest-50000-in-right-now/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/best-stocks-invest-50-000-084600763.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "NVDA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]